| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000041044 |
| Receipt No. | R000046873 |
| Scientific Title | Verification of the reducing effect on oxidative stress by daily intake of miso soup made with miso paste |
| Date of disclosure of the study information | 2020/07/09 |
| Last modified on | 2021/01/07 (Ver. 3) |
| Basic information | ||
| Public title | Verification of the reducing effect on oxidative stress by daily intake of miso soup made with miso paste | |
| Acronym | Verification of the reducing effect on oxidative stress by daily intake of miso soup made with miso paste | |
| Scientific Title | Verification of the reducing effect on oxidative stress by daily intake of miso soup made with miso paste | |
| Scientific Title:Acronym | Verification of the reducing effect on oxidative stress by daily intake of miso soup made with miso paste | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Do an exploratory evaluation of the reducing effect on oxidative stress for adults (over 20 years old) by miso soup intake for four weeks. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Oxidative stress level (urinary 8-OHdG, urinary creatinine) at the beginning of or after the intake for four weeks. |
| Key secondary outcomes | Questionnaire(about defecation, stress and skin), urinary sodium, urinary indoxyl sulfate and urinary protein at the beginning of or after the intake for four weeks. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake a cup of miso soup made with 18g "HONBA AKADASHI 500g" twice a day daily for four weeks | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2.Japanese who are over 20 years old 3.Persons who take five cups or less of miso soup a week 4.Persons who can continuously take miso soup made with Aka dashi during study 5.Persons who have lifestyle that are considered to have high oxidative stress according to the pre-questionnaire |
|||
| Key exclusion criteria | 1.Persons who have chronic illness,
2.Persons who are allergic to soy 3.Persons who daily use medicines, foods for specified health uses, health foods and supplements that may have anti oxidative effect 4.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 5.Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Healthcare Systems Co., Ltd. | ||||||
| Division name | Sales planning Department | ||||||
| Zip code | 105-0004 | ||||||
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN | ||||||
| TEL | 0368092722 | ||||||
| yasutake@hc-sys.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Healthcare Systems Co., Ltd. | ||||||
| Division name | Sales Planning Department | ||||||
| Zip code | 105-0004 | ||||||
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN | ||||||
| TEL | 080-4374-2722 | ||||||
| Homepage URL | |||||||
| matsumoto@hc-sys.jp | |||||||
| Sponsor | |
| Institute | Healthcare Systems Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | MARUSAN-AI Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Ethics Committee of Healthcare Systems Co., Ltd. |
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
| Tel | 03-6809-2722 |
| soumu@hc-sys.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 30 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046873 |